Head & Neck

1789 views 180 hours watched
19:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

FEATURING Katie Kerrigan
  • 66 views
  • August 27, 2024
08:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovorafenib in R/R Pediatric Low Grade Glioma"

FEATURING David Ziegler
  • 107 views
  • July 11, 2024
  • 2
07:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination With Cetuximab in Patients With mCRC and HNSCC"

FEATURING Susanna Ulahannan
  • 28 views
  • July 3, 2024
06:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Petosemtamab With Pembro as 1L Treatment of Recurrent/Metastatic HNSCC"

FEATURING Cesar Perez
  • 75 views
  • July 3, 2024
21:12

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

FEATURING Nabil Saba
  • 904 views
  • June 13, 2024
  • 4
25:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "News in Head&Neck Cancers"

FEATURING Paolo Bossi
  • 433 views
  • June 14, 2024
  • 9
05:00

ecancer

ASCO® 2024 Insights: "E3311 Trial - Enhancing Oropharynx Cancer Outcomes With Transoral Surgery and Deintensified Post-Op Care"

FEATURING Barbara Burtness
  • 33 views
  • June 20, 2024
08:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Triple Oral Metronomic Therapy + Chemo Regimen vs. Chemo Alone in Advanced Unresectable HNSCC"

FEATURING Akhil Kapoor
  • 75 views
  • June 12, 2024
  • 2
07:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

FEATURING Scott Norberg
  • 68 views
  • June 7, 2024
  • 1